Skip Navigation



JAC Advance Access published online on May 30, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl186
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
58/2/408    most recent
dkl186v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ferech, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferech, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Received August 23, 2005
Revised April 12, 2006
Accepted April 16, 2006

Original article

European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe

Matus Ferech 1 * {dagger}, Samuel Coenen 2 {dagger}, Katerina Dvorakova 1, Erik Hendrickx 3, Carl Suetens 3, Herman Goossens 4, and on behalf of the ESAC Project Group {ddagger}

1 Laboratory of Microbiology, University of Antwerp, Antwerp, Belgium
2 Department of General Practice, University of Antwerp, Antwerp, Belgium; Fund for Scientific Research--Flanders, Brussels, Belgium
3 Unit of Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
4 Laboratory of Microbiology, University of Antwerp, Antwerp, Belgium; Laboratory of Microbiology, Leiden University Medical Center, Leiden, The Netherlands

* To whom correspondence should be addressed.
Matus Ferech, E-mail: matus.ferech{at}ua.ac.be


  Abstract

Background: Data on outpatient penicillin use in Europe were collected from 25 countries within the ESAC project, funded by DG SANCO of the European Commission, using the WHO ATC/DDD methodology.

Methods: For the period 1997-2003, data on outpatient use of systemic penicillins aggregated at the level of the active substance were collected and expressed in DDD (WHO, version 2004) per 1000 inhabitants per day (DID). Of the ‘Penicillins’ (J01C), outpatient use of narrow-spectrum penicillins (J01CE), broad-spectrum penicillins (J01CA), penicillinase-resistant penicillins (J01CF) and combinations with {beta}-lactamase inhibitors (J01CR) in 25 European countries was analysed in detail.

Results: Total outpatient penicillin use in 2003 varied by a factor of 4 between the country with the highest (15.27 DID in Slovakia) and lowest use (3.86 DID in the Netherlands). Narrow-spectrum penicillins, broad-spectrum penicillins and combinations with {beta}-lactamase inhibitors were used most in 4, 12 and 9 countries, respectively. Penicillin use increased by more than 1 DID in nine countries, whereas it decreased by more than 1 DID in two countries (Czech Republic, France). An increase of the use of combinations with {beta}-lactamase inhibitors by more than 10% in 10 countries coincided with an equal decrease of broad-spectrum penicillins in seven countries and narrow-spectrum penicillins in three countries.

Conclusion: Penicillins represent the most widely used antibiotic class in all 25 participating countries; albeit with considerable variation of their use patterns. A distinct shift from narrow-spectrum penicillins to broad-spectrum penicillins, and specifically their combinations with {beta}-lactamase inhibitors, was observed during the period 1997-2003.

Keywords: antibiotic use; penicillins; drug consumption; pharmacoepidemiology; ambulatory care; Europe.

{dagger}These authors contributed equally to this work.

{ddagger}Members are listed in the Acknowledgements section.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
S. Coenen, A. Muller, N. Adriaenssens, V. Vankerckhoven, E. Hendrickx, H. Goossens, and on behalf of the ESAC Project Group
European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe
J. Antimicrob. Chemother., July 1, 2009; 64(1): 200 - 205.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
I. M. Gould
Who's winning the war?
J. Antimicrob. Chemother., November 1, 2008; 62(suppl_3): iii3 - iii6.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
L. Dong, H. Yan, and D. Wang
Antibiotic prescribing patterns in village health clinics across 10 provinces of Western China
J. Antimicrob. Chemother., August 1, 2008; 62(2): 410 - 415.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. E. Mroczkowska and M. Barlow
Fitness Trade-Offs in blaTEM Evolution
Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2340 - 2345.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. Flamaing, J. Verhaegen, J. Vandeven, N. Verbiest, and W. E. Peetermans
Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era
J. Antimicrob. Chemother., January 1, 2008; 61(1): 143 - 149.
[Abstract] [Full Text] [PDF]

Home page
 Qual Saf Health CareHome page
S. Coenen, M. Ferech, F. M Haaijer-Ruskamp, C. C Butler, R. H Vander Stichele, T. J M Verheij, D. L Monnet, P. Little, H. Goossens, and the ESAC Project Group
European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe
Qual. Saf. Health Care, December 1, 2007; 16(6): 440 - 445.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
H. S. Blix, A. Engeland, I. Litleskare, and M. Ronning
Age- and gender-specific antibacterial prescribing in Norway
J. Antimicrob. Chemother., May 1, 2007; 59(5): 971 - 976.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
S. Coenen, M. Ferech, S. Malhotra-Kumar, E. Hendrickx, C. Suetens, H. Goossens, and on behalf of the ESAC Project Group
European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe
J. Antimicrob. Chemother., August 1, 2006; 58(2): 418 - 422.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. Ferech, S. Coenen, S. Malhotra-Kumar, K. Dvorakova, E. Hendrickx, C. Suetens, H. Goossens, and on behalf of the ESAC Project Group
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe
J. Antimicrob. Chemother., August 1, 2006; 58(2): 401 - 407.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.